
Daniel L. Branson
Examiner (ID: 6482, Phone: (571)270-3812 , Office: P/1616 )
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1616 |
| Total Applications | 476 |
| Issued Applications | 205 |
| Pending Applications | 3 |
| Abandoned Applications | 267 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6271507
[patent_doc_number] => 20100255122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'EDIBLE GELATIN BOWEL PREPARATION AND BOWEL CLEANSING METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/752406
[patent_app_country] => US
[patent_app_date] => 2010-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1202
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20100255122.pdf
[firstpage_image] =>[orig_patent_app_number] => 12752406
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/752406 | EDIBLE GELATIN BOWEL PREPARATION AND BOWEL CLEANSING METHOD | Mar 31, 2010 | Abandoned |
Array
(
[id] => 8210978
[patent_doc_number] => 20120129693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'SEED HAVING INOCULATED WITH BACTERIAL BILFILM'
[patent_app_type] => utility
[patent_app_number] => 13/322045
[patent_app_country] => US
[patent_app_date] => 2010-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3981
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20120129693.pdf
[firstpage_image] =>[orig_patent_app_number] => 13322045
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/322045 | SEED HAVING INOCULATED WITH BACTERIAL BILFILM | Mar 29, 2010 | Abandoned |
Array
(
[id] => 6271133
[patent_doc_number] => 20100255046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'COSMETIC POWDER COATED WITH ALKOXY SILICONES'
[patent_app_type] => utility
[patent_app_number] => 12/749336
[patent_app_country] => US
[patent_app_date] => 2010-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3968
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20100255046.pdf
[firstpage_image] =>[orig_patent_app_number] => 12749336
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/749336 | Cosmetic powder coated with alkoxy silicones | Mar 28, 2010 | Issued |
Array
(
[id] => 7697010
[patent_doc_number] => 20110229580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'COMPOSITIONS AND METHODS FOR NANO-IN-MICRO PARTICLES'
[patent_app_type] => utility
[patent_app_number] => 12/728936
[patent_app_country] => US
[patent_app_date] => 2010-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 20541
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20110229580.pdf
[firstpage_image] =>[orig_patent_app_number] => 12728936
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/728936 | COMPOSITIONS AND METHODS FOR NANO-IN-MICRO PARTICLES | Mar 21, 2010 | Abandoned |
Array
(
[id] => 7697007
[patent_doc_number] => 20110229583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'Human Medicinal Treatment Typically Using Salt of Peroxymonosulfuric Acid'
[patent_app_type] => utility
[patent_app_number] => 12/726326
[patent_app_country] => US
[patent_app_date] => 2010-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32871
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20110229583.pdf
[firstpage_image] =>[orig_patent_app_number] => 12726326
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/726326 | Human medicinal treatment using salt of peroxymonosulfuric acid | Mar 16, 2010 | Issued |
Array
(
[id] => 8016411
[patent_doc_number] => 08137704
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-20
[patent_title] => 'Method of manufacturing digestible powder that generates hydride ion (H-)'
[patent_app_type] => utility
[patent_app_number] => 12/716564
[patent_app_country] => US
[patent_app_date] => 2010-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3878
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/137/08137704.pdf
[firstpage_image] =>[orig_patent_app_number] => 12716564
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/716564 | Method of manufacturing digestible powder that generates hydride ion (H-) | Mar 2, 2010 | Issued |
Array
(
[id] => 7790579
[patent_doc_number] => 20120052135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-01
[patent_title] => 'Phosphate Adsorbent'
[patent_app_type] => utility
[patent_app_number] => 13/202586
[patent_app_country] => US
[patent_app_date] => 2010-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10909
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20120052135.pdf
[firstpage_image] =>[orig_patent_app_number] => 13202586
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/202586 | Phosphate Adsorbent | Feb 28, 2010 | Abandoned |
Array
(
[id] => 6552471
[patent_doc_number] => 20100233289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'Antimicrobial acid formulation'
[patent_app_type] => utility
[patent_app_number] => 12/660016
[patent_app_country] => US
[patent_app_date] => 2010-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13627
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20100233289.pdf
[firstpage_image] =>[orig_patent_app_number] => 12660016
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/660016 | Antimicrobial acid formulation | Feb 17, 2010 | Abandoned |
Array
(
[id] => 7817546
[patent_doc_number] => 20120064166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'FORMULATION COMPRISING DROSPIRENONE FOR SUBCUTANEOUS OR INTRAMUSCULAR ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 13/201856
[patent_app_country] => US
[patent_app_date] => 2010-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9406
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20120064166.pdf
[firstpage_image] =>[orig_patent_app_number] => 13201856
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/201856 | FORMULATION COMPRISING DROSPIRENONE FOR SUBCUTANEOUS OR INTRAMUSCULAR ADMINISTRATION | Feb 11, 2010 | Abandoned |
Array
(
[id] => 11678181
[patent_doc_number] => 09676696
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-13
[patent_title] => 'Regulation of mammalian keratinous tissue using skin and/or hair care actives'
[patent_app_type] => utility
[patent_app_number] => 12/692826
[patent_app_country] => US
[patent_app_date] => 2010-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11387
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12692826
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/692826 | Regulation of mammalian keratinous tissue using skin and/or hair care actives | Jan 24, 2010 | Issued |
Array
(
[id] => 9482206
[patent_doc_number] => 08728150
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-20
[patent_title] => 'Medical device loaded with formulation for targeted delivery of biologically active material/s and method of manufacture thereof'
[patent_app_type] => utility
[patent_app_number] => 13/145386
[patent_app_country] => US
[patent_app_date] => 2010-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11095
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13145386
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/145386 | Medical device loaded with formulation for targeted delivery of biologically active material/s and method of manufacture thereof | Jan 20, 2010 | Issued |
Array
(
[id] => 7669162
[patent_doc_number] => 20110318431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'Pharmaceutical Compositions and Methods of Treating Neurological Insults'
[patent_app_type] => utility
[patent_app_number] => 13/142675
[patent_app_country] => US
[patent_app_date] => 2009-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12030
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13142675
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/142675 | Pharmaceutical Compositions and Methods of Treating Neurological Insults | Dec 28, 2009 | Abandoned |
Array
(
[id] => 7511306
[patent_doc_number] => 20110257016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'Gel Formulations that are Stable for Storage, Comprising at Least Two Substantially Unmixed Hydrogels'
[patent_app_type] => utility
[patent_app_number] => 13/140934
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15717
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20110257016.pdf
[firstpage_image] =>[orig_patent_app_number] => 13140934
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/140934 | Gel Formulations that are Stable for Storage, Comprising at Least Two Substantially Unmixed Hydrogels | Dec 21, 2009 | Abandoned |
Array
(
[id] => 5969355
[patent_doc_number] => 20110151027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'STRONTIUM-DOPED CALCIUM PHOSPHATE BONE GRAFT MATERIALS'
[patent_app_type] => utility
[patent_app_number] => 12/643218
[patent_app_country] => US
[patent_app_date] => 2009-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 7308
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20110151027.pdf
[firstpage_image] =>[orig_patent_app_number] => 12643218
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/643218 | STRONTIUM-DOPED CALCIUM PHOSPHATE BONE GRAFT MATERIALS | Dec 20, 2009 | Abandoned |
Array
(
[id] => 8385738
[patent_doc_number] => 08263132
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-11
[patent_title] => 'Methods for preparing pharmaceuticals by emulsion aggregation processes'
[patent_app_type] => utility
[patent_app_number] => 12/640164
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5967
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12640164
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/640164 | Methods for preparing pharmaceuticals by emulsion aggregation processes | Dec 16, 2009 | Issued |
Array
(
[id] => 7650955
[patent_doc_number] => 20110300224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'TASTE MASKED DOSAGE FORM OF PHARMACEUTICALLY ACCEPTABLE SALT OF ESCITALOPRAM'
[patent_app_type] => utility
[patent_app_number] => 13/125736
[patent_app_country] => US
[patent_app_date] => 2009-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3097
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20110300224.pdf
[firstpage_image] =>[orig_patent_app_number] => 13125736
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/125736 | TASTE MASKED DOSAGE FORM OF PHARMACEUTICALLY ACCEPTABLE SALT OF ESCITALOPRAM | Dec 10, 2009 | Abandoned |
Array
(
[id] => 10089249
[patent_doc_number] => 09126057
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-08
[patent_title] => 'Hair conditioning composition comprising cationic surfactant system and direct dye'
[patent_app_type] => utility
[patent_app_number] => 12/635826
[patent_app_country] => US
[patent_app_date] => 2009-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8248
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12635826
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/635826 | Hair conditioning composition comprising cationic surfactant system and direct dye | Dec 10, 2009 | Issued |
Array
(
[id] => 7742491
[patent_doc_number] => 20120021067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'MAINTENANCE FLUID FOR ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 13/142410
[patent_app_country] => US
[patent_app_date] => 2009-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1743
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20120021067.pdf
[firstpage_image] =>[orig_patent_app_number] => 13142410
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/142410 | MAINTENANCE FLUID FOR ANIMALS | Dec 9, 2009 | Abandoned |
Array
(
[id] => 9761789
[patent_doc_number] => 08846108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-30
[patent_title] => 'Antimicrobial body affecting products'
[patent_app_type] => utility
[patent_app_number] => 12/592693
[patent_app_country] => US
[patent_app_date] => 2009-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 14
[patent_no_of_words] => 7485
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12592693
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/592693 | Antimicrobial body affecting products | Nov 30, 2009 | Issued |
Array
(
[id] => 7487716
[patent_doc_number] => 20110236508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'L-ARGININE-BASED FORMULATION FOR ORAL ABSORPTION'
[patent_app_type] => utility
[patent_app_number] => 13/131869
[patent_app_country] => US
[patent_app_date] => 2009-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10459
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20110236508.pdf
[firstpage_image] =>[orig_patent_app_number] => 13131869
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/131869 | L-ARGININE-BASED FORMULATION FOR ORAL ABSORPTION | Nov 29, 2009 | Abandoned |